Prevalence and Dynamics of Circulating Tumor DNA (ctdna) among Patients (pts) with HER2+ Breast Cancer (BC) Receiving Neoadjuvant Paclitaxel/trastuzumab/pertuzumab (THP) in the DAPHNe Trial.Adrienne Gropper Waks,Paolo Tarantino,Tianyu Li,Esther R. Ogayo,Tasnim Rahman,Molly DiLullo,Sherif Mohamed El-Refai,Charles Abbott,Sean Michael Boyle,Richard Chen,Neelam Vijay Desai,Laura Spring,Nadine M. Tung,Tari A. King,Ian E. Krop,Nabihah Tayob,Elizabeth A. Mittendorf,Sara M. Tolaney,Eric P. Winer,Heather Anne ParsonsJournal of Clinical Oncology（2024）引用 0|浏览31AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
